IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. Mediterr J Hematol Infect Dis 2021, 13 (1), e2021062. https://doi.org/10.4084/MJHID.2021.062.